Pharmacologic chaperoning as a strategy to treat Gaucher disease
- PMID: 17894779
- DOI: 10.1111/j.1742-4658.2007.06042.x
Pharmacologic chaperoning as a strategy to treat Gaucher disease
Abstract
We briefly introduce the most common lysosomal storage disorder, Gaucher disease, concisely describe the Food and Drug Administration approved strategies to ameliorate Gaucher disease, and then outline the emerging pharmacologic chaperone strategy that offers the promise to remedy this malady.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
